ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pruritus Ani Medicine Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-31G14328
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pruritus Ani Medicine Market Research Report 2023
BUY CHAPTERS

Global Pruritus Ani Medicine Market Research Report 2025

Code: QYRE-Auto-31G14328
Report
May 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbvie inc. (Allergan Plc)
Albireo Pharma Inc
GSK
Merck& Co. Inc
Pfizer Inc
Viatris Inc. (Mylan N.V.)
Astellas Pharma Inc
Cipla Ltd
Eli Lilly and Company
Teva Pharmaceutical Industries Ltd

Pruritus Ani Medicine Market Size

The global market for Pruritus Ani Medicine was valued at US$ 928 million in the year 2024 and is projected to reach a revised size of US$ 1283 million by 2031, growing at a CAGR of 4.8% during the forecast period.

Pruritus Ani Medicine Market

Pruritus Ani Medicine Market

North American market for Pruritus Ani Medicine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pruritus Ani Medicine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Pruritus Ani Medicine include AbbVie, Inc. (Allergan plc), Albireo Pharma, Inc., Astellas Pharma Inc., Cipla Limited, Eli Lilly and Company, GSK plc, Merck & Co., Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc. (Mylan N.V.), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pruritus Ani Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pruritus Ani Medicine.
The Pruritus Ani Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pruritus Ani Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pruritus Ani Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pruritus Ani Medicine Market Report

Report Metric Details
Report Name Pruritus Ani Medicine Market
Accounted market size in year US$ 928 million
Forecasted market size in 2031 US$ 1283 million
CAGR 4.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • External Medication
  • Oral Medication
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie, Inc. (Allergan plc), Albireo Pharma, Inc., Astellas Pharma Inc., Cipla Limited, Eli Lilly and Company, GSK plc, Merck & Co., Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc. (Mylan N.V.)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pruritus Ani Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pruritus Ani Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Pruritus Ani Medicine Market growing?

Ans: The Pruritus Ani Medicine Market witnessing a CAGR of 4.8% during the forecast period 2025-2031.

What is the Pruritus Ani Medicine Market size in 2031?

Ans: The Pruritus Ani Medicine Market size in 2031 will be US$ 1283 million.

Who are the main players in the Pruritus Ani Medicine Market report?

Ans: The main players in the Pruritus Ani Medicine Market are AbbVie, Inc. (Allergan plc), Albireo Pharma, Inc., Astellas Pharma Inc., Cipla Limited, Eli Lilly and Company, GSK plc, Merck & Co., Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc. (Mylan N.V.)

What are the Application segmentation covered in the Pruritus Ani Medicine Market report?

Ans: The Applications covered in the Pruritus Ani Medicine Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Pruritus Ani Medicine Market report?

Ans: The Types covered in the Pruritus Ani Medicine Market report are External Medication, Oral Medication

1 Pruritus Ani Medicine Market Overview
1.1 Product Definition
1.2 Pruritus Ani Medicine by Type
1.2.1 Global Pruritus Ani Medicine Market Value Comparison by Type (2024 VS 2031)
1.2.2 External Medication
1.2.3 Oral Medication
1.3 Pruritus Ani Medicine by Application
1.3.1 Global Pruritus Ani Medicine Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Pruritus Ani Medicine Market Size Estimates and Forecasts
1.4.1 Global Pruritus Ani Medicine Revenue 2020-2031
1.4.2 Global Pruritus Ani Medicine Sales 2020-2031
1.4.3 Global Pruritus Ani Medicine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pruritus Ani Medicine Market Competition by Manufacturers
2.1 Global Pruritus Ani Medicine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pruritus Ani Medicine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pruritus Ani Medicine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pruritus Ani Medicine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pruritus Ani Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pruritus Ani Medicine, Product Type & Application
2.7 Global Key Manufacturers of Pruritus Ani Medicine, Date of Enter into This Industry
2.8 Global Pruritus Ani Medicine Market Competitive Situation and Trends
2.8.1 Global Pruritus Ani Medicine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pruritus Ani Medicine Players Market Share by Revenue
2.8.3 Global Pruritus Ani Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pruritus Ani Medicine Market Scenario by Region
3.1 Global Pruritus Ani Medicine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pruritus Ani Medicine Sales by Region: 2020-2031
3.2.1 Global Pruritus Ani Medicine Sales by Region: 2020-2025
3.2.2 Global Pruritus Ani Medicine Sales by Region: 2026-2031
3.3 Global Pruritus Ani Medicine Revenue by Region: 2020-2031
3.3.1 Global Pruritus Ani Medicine Revenue by Region: 2020-2025
3.3.2 Global Pruritus Ani Medicine Revenue by Region: 2026-2031
3.4 North America Pruritus Ani Medicine Market Facts & Figures by Country
3.4.1 North America Pruritus Ani Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pruritus Ani Medicine Sales by Country (2020-2031)
3.4.3 North America Pruritus Ani Medicine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pruritus Ani Medicine Market Facts & Figures by Country
3.5.1 Europe Pruritus Ani Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pruritus Ani Medicine Sales by Country (2020-2031)
3.5.3 Europe Pruritus Ani Medicine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pruritus Ani Medicine Market Facts & Figures by Region
3.6.1 Asia Pacific Pruritus Ani Medicine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pruritus Ani Medicine Sales by Region (2020-2031)
3.6.3 Asia Pacific Pruritus Ani Medicine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pruritus Ani Medicine Market Facts & Figures by Country
3.7.1 Latin America Pruritus Ani Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pruritus Ani Medicine Sales by Country (2020-2031)
3.7.3 Latin America Pruritus Ani Medicine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pruritus Ani Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pruritus Ani Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pruritus Ani Medicine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pruritus Ani Medicine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pruritus Ani Medicine Sales by Type (2020-2031)
4.1.1 Global Pruritus Ani Medicine Sales by Type (2020-2025)
4.1.2 Global Pruritus Ani Medicine Sales by Type (2026-2031)
4.1.3 Global Pruritus Ani Medicine Sales Market Share by Type (2020-2031)
4.2 Global Pruritus Ani Medicine Revenue by Type (2020-2031)
4.2.1 Global Pruritus Ani Medicine Revenue by Type (2020-2025)
4.2.2 Global Pruritus Ani Medicine Revenue by Type (2026-2031)
4.2.3 Global Pruritus Ani Medicine Revenue Market Share by Type (2020-2031)
4.3 Global Pruritus Ani Medicine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pruritus Ani Medicine Sales by Application (2020-2031)
5.1.1 Global Pruritus Ani Medicine Sales by Application (2020-2025)
5.1.2 Global Pruritus Ani Medicine Sales by Application (2026-2031)
5.1.3 Global Pruritus Ani Medicine Sales Market Share by Application (2020-2031)
5.2 Global Pruritus Ani Medicine Revenue by Application (2020-2031)
5.2.1 Global Pruritus Ani Medicine Revenue by Application (2020-2025)
5.2.2 Global Pruritus Ani Medicine Revenue by Application (2026-2031)
5.2.3 Global Pruritus Ani Medicine Revenue Market Share by Application (2020-2031)
5.3 Global Pruritus Ani Medicine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AbbVie, Inc. (Allergan plc)
6.1.1 AbbVie, Inc. (Allergan plc) Company Information
6.1.2 AbbVie, Inc. (Allergan plc) Description and Business Overview
6.1.3 AbbVie, Inc. (Allergan plc) Pruritus Ani Medicine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AbbVie, Inc. (Allergan plc) Pruritus Ani Medicine Product Portfolio
6.1.5 AbbVie, Inc. (Allergan plc) Recent Developments/Updates
6.2 Albireo Pharma, Inc.
6.2.1 Albireo Pharma, Inc. Company Information
6.2.2 Albireo Pharma, Inc. Description and Business Overview
6.2.3 Albireo Pharma, Inc. Pruritus Ani Medicine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Albireo Pharma, Inc. Pruritus Ani Medicine Product Portfolio
6.2.5 Albireo Pharma, Inc. Recent Developments/Updates
6.3 Astellas Pharma Inc.
6.3.1 Astellas Pharma Inc. Company Information
6.3.2 Astellas Pharma Inc. Description and Business Overview
6.3.3 Astellas Pharma Inc. Pruritus Ani Medicine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Astellas Pharma Inc. Pruritus Ani Medicine Product Portfolio
6.3.5 Astellas Pharma Inc. Recent Developments/Updates
6.4 Cipla Limited
6.4.1 Cipla Limited Company Information
6.4.2 Cipla Limited Description and Business Overview
6.4.3 Cipla Limited Pruritus Ani Medicine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cipla Limited Pruritus Ani Medicine Product Portfolio
6.4.5 Cipla Limited Recent Developments/Updates
6.5 Eli Lilly and Company
6.5.1 Eli Lilly and Company Company Information
6.5.2 Eli Lilly and Company Description and Business Overview
6.5.3 Eli Lilly and Company Pruritus Ani Medicine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Eli Lilly and Company Pruritus Ani Medicine Product Portfolio
6.5.5 Eli Lilly and Company Recent Developments/Updates
6.6 GSK plc
6.6.1 GSK plc Company Information
6.6.2 GSK plc Description and Business Overview
6.6.3 GSK plc Pruritus Ani Medicine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GSK plc Pruritus Ani Medicine Product Portfolio
6.6.5 GSK plc Recent Developments/Updates
6.7 Merck & Co., Inc.
6.7.1 Merck & Co., Inc. Company Information
6.7.2 Merck & Co., Inc. Description and Business Overview
6.7.3 Merck & Co., Inc. Pruritus Ani Medicine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck & Co., Inc. Pruritus Ani Medicine Product Portfolio
6.7.5 Merck & Co., Inc. Recent Developments/Updates
6.8 Pfizer, Inc.
6.8.1 Pfizer, Inc. Company Information
6.8.2 Pfizer, Inc. Description and Business Overview
6.8.3 Pfizer, Inc. Pruritus Ani Medicine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Pfizer, Inc. Pruritus Ani Medicine Product Portfolio
6.8.5 Pfizer, Inc. Recent Developments/Updates
6.9 Teva Pharmaceutical Industries Ltd.
6.9.1 Teva Pharmaceutical Industries Ltd. Company Information
6.9.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
6.9.3 Teva Pharmaceutical Industries Ltd. Pruritus Ani Medicine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Teva Pharmaceutical Industries Ltd. Pruritus Ani Medicine Product Portfolio
6.9.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
6.10 Viatris Inc. (Mylan N.V.)
6.10.1 Viatris Inc. (Mylan N.V.) Company Information
6.10.2 Viatris Inc. (Mylan N.V.) Description and Business Overview
6.10.3 Viatris Inc. (Mylan N.V.) Pruritus Ani Medicine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Viatris Inc. (Mylan N.V.) Pruritus Ani Medicine Product Portfolio
6.10.5 Viatris Inc. (Mylan N.V.) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pruritus Ani Medicine Industry Chain Analysis
7.2 Pruritus Ani Medicine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pruritus Ani Medicine Production Mode & Process Analysis
7.4 Pruritus Ani Medicine Sales and Marketing
7.4.1 Pruritus Ani Medicine Sales Channels
7.4.2 Pruritus Ani Medicine Distributors
7.5 Pruritus Ani Medicine Customer Analysis
8 Pruritus Ani Medicine Market Dynamics
8.1 Pruritus Ani Medicine Industry Trends
8.2 Pruritus Ani Medicine Market Drivers
8.3 Pruritus Ani Medicine Market Challenges
8.4 Pruritus Ani Medicine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Abbvie inc. (Allergan Plc)
Albireo Pharma Inc
GSK
Merck& Co. Inc
Pfizer Inc
Viatris Inc. (Mylan N.V.)
Astellas Pharma Inc
Cipla Ltd
Eli Lilly and Company
Teva Pharmaceutical Industries Ltd
List of Tables
 Table 1. Global Pruritus Ani Medicine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pruritus Ani Medicine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pruritus Ani Medicine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pruritus Ani Medicine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Pruritus Ani Medicine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pruritus Ani Medicine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pruritus Ani Medicine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pruritus Ani Medicine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pruritus Ani Medicine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pruritus Ani Medicine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pruritus Ani Medicine, Product Type & Application
 Table 12. Global Key Manufacturers of Pruritus Ani Medicine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pruritus Ani Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pruritus Ani Medicine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pruritus Ani Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pruritus Ani Medicine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Pruritus Ani Medicine Sales Market Share by Region (2020-2025)
 Table 19. Global Pruritus Ani Medicine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Pruritus Ani Medicine Sales Market Share by Region (2026-2031)
 Table 21. Global Pruritus Ani Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pruritus Ani Medicine Revenue Market Share by Region (2020-2025)
 Table 23. Global Pruritus Ani Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pruritus Ani Medicine Revenue Market Share by Region (2026-2031)
 Table 25. North America Pruritus Ani Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pruritus Ani Medicine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Pruritus Ani Medicine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Pruritus Ani Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pruritus Ani Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pruritus Ani Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pruritus Ani Medicine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Pruritus Ani Medicine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Pruritus Ani Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pruritus Ani Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pruritus Ani Medicine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pruritus Ani Medicine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Pruritus Ani Medicine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Pruritus Ani Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pruritus Ani Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pruritus Ani Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pruritus Ani Medicine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Pruritus Ani Medicine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Pruritus Ani Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pruritus Ani Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pruritus Ani Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pruritus Ani Medicine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Pruritus Ani Medicine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Pruritus Ani Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pruritus Ani Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pruritus Ani Medicine Sales (K Units) by Type (2020-2025)
 Table 51. Global Pruritus Ani Medicine Sales (K Units) by Type (2026-2031)
 Table 52. Global Pruritus Ani Medicine Sales Market Share by Type (2020-2025)
 Table 53. Global Pruritus Ani Medicine Sales Market Share by Type (2026-2031)
 Table 54. Global Pruritus Ani Medicine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pruritus Ani Medicine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pruritus Ani Medicine Revenue Market Share by Type (2020-2025)
 Table 57. Global Pruritus Ani Medicine Revenue Market Share by Type (2026-2031)
 Table 58. Global Pruritus Ani Medicine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Pruritus Ani Medicine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Pruritus Ani Medicine Sales (K Units) by Application (2020-2025)
 Table 61. Global Pruritus Ani Medicine Sales (K Units) by Application (2026-2031)
 Table 62. Global Pruritus Ani Medicine Sales Market Share by Application (2020-2025)
 Table 63. Global Pruritus Ani Medicine Sales Market Share by Application (2026-2031)
 Table 64. Global Pruritus Ani Medicine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pruritus Ani Medicine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pruritus Ani Medicine Revenue Market Share by Application (2020-2025)
 Table 67. Global Pruritus Ani Medicine Revenue Market Share by Application (2026-2031)
 Table 68. Global Pruritus Ani Medicine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Pruritus Ani Medicine Price (US$/Unit) by Application (2026-2031)
 Table 70. AbbVie, Inc. (Allergan plc) Company Information
 Table 71. AbbVie, Inc. (Allergan plc) Description and Business Overview
 Table 72. AbbVie, Inc. (Allergan plc) Pruritus Ani Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AbbVie, Inc. (Allergan plc) Pruritus Ani Medicine Product
 Table 74. AbbVie, Inc. (Allergan plc) Recent Developments/Updates
 Table 75. Albireo Pharma, Inc. Company Information
 Table 76. Albireo Pharma, Inc. Description and Business Overview
 Table 77. Albireo Pharma, Inc. Pruritus Ani Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Albireo Pharma, Inc. Pruritus Ani Medicine Product
 Table 79. Albireo Pharma, Inc. Recent Developments/Updates
 Table 80. Astellas Pharma Inc. Company Information
 Table 81. Astellas Pharma Inc. Description and Business Overview
 Table 82. Astellas Pharma Inc. Pruritus Ani Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Astellas Pharma Inc. Pruritus Ani Medicine Product
 Table 84. Astellas Pharma Inc. Recent Developments/Updates
 Table 85. Cipla Limited Company Information
 Table 86. Cipla Limited Description and Business Overview
 Table 87. Cipla Limited Pruritus Ani Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Cipla Limited Pruritus Ani Medicine Product
 Table 89. Cipla Limited Recent Developments/Updates
 Table 90. Eli Lilly and Company Company Information
 Table 91. Eli Lilly and Company Description and Business Overview
 Table 92. Eli Lilly and Company Pruritus Ani Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Eli Lilly and Company Pruritus Ani Medicine Product
 Table 94. Eli Lilly and Company Recent Developments/Updates
 Table 95. GSK plc Company Information
 Table 96. GSK plc Description and Business Overview
 Table 97. GSK plc Pruritus Ani Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. GSK plc Pruritus Ani Medicine Product
 Table 99. GSK plc Recent Developments/Updates
 Table 100. Merck & Co., Inc. Company Information
 Table 101. Merck & Co., Inc. Description and Business Overview
 Table 102. Merck & Co., Inc. Pruritus Ani Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Merck & Co., Inc. Pruritus Ani Medicine Product
 Table 104. Merck & Co., Inc. Recent Developments/Updates
 Table 105. Pfizer, Inc. Company Information
 Table 106. Pfizer, Inc. Description and Business Overview
 Table 107. Pfizer, Inc. Pruritus Ani Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Pfizer, Inc. Pruritus Ani Medicine Product
 Table 109. Pfizer, Inc. Recent Developments/Updates
 Table 110. Teva Pharmaceutical Industries Ltd. Company Information
 Table 111. Teva Pharmaceutical Industries Ltd. Description and Business Overview
 Table 112. Teva Pharmaceutical Industries Ltd. Pruritus Ani Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Teva Pharmaceutical Industries Ltd. Pruritus Ani Medicine Product
 Table 114. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
 Table 115. Viatris Inc. (Mylan N.V.) Company Information
 Table 116. Viatris Inc. (Mylan N.V.) Description and Business Overview
 Table 117. Viatris Inc. (Mylan N.V.) Pruritus Ani Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Viatris Inc. (Mylan N.V.) Pruritus Ani Medicine Product
 Table 119. Viatris Inc. (Mylan N.V.) Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Pruritus Ani Medicine Distributors List
 Table 123. Pruritus Ani Medicine Customers List
 Table 124. Pruritus Ani Medicine Market Trends
 Table 125. Pruritus Ani Medicine Market Drivers
 Table 126. Pruritus Ani Medicine Market Challenges
 Table 127. Pruritus Ani Medicine Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pruritus Ani Medicine
 Figure 2. Global Pruritus Ani Medicine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pruritus Ani Medicine Market Share by Type: 2024 & 2031
 Figure 4. External Medication Product Picture
 Figure 5. Oral Medication Product Picture
 Figure 6. Global Pruritus Ani Medicine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pruritus Ani Medicine Market Share by Application: 2024 & 2031
 Figure 8. Hospital Pharmacies
 Figure 9. Retail Pharmacies
 Figure 10. Online Pharmacies
 Figure 11. Global Pruritus Ani Medicine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Pruritus Ani Medicine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Pruritus Ani Medicine Sales (2020-2031) & (K Units)
 Figure 14. Global Pruritus Ani Medicine Average Price (US$/Unit) & (2020-2031)
 Figure 15. Pruritus Ani Medicine Report Years Considered
 Figure 16. Pruritus Ani Medicine Sales Share by Manufacturers in 2024
 Figure 17. Global Pruritus Ani Medicine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Pruritus Ani Medicine Players: Market Share by Revenue in Pruritus Ani Medicine in 2024
 Figure 19. Pruritus Ani Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Pruritus Ani Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Pruritus Ani Medicine Sales Market Share by Country (2020-2031)
 Figure 22. North America Pruritus Ani Medicine Revenue Market Share by Country (2020-2031)
 Figure 23. United States Pruritus Ani Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Pruritus Ani Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Pruritus Ani Medicine Sales Market Share by Country (2020-2031)
 Figure 26. Europe Pruritus Ani Medicine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Pruritus Ani Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Pruritus Ani Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Pruritus Ani Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Pruritus Ani Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Pruritus Ani Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Pruritus Ani Medicine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Pruritus Ani Medicine Revenue Market Share by Region (2020-2031)
 Figure 34. China Pruritus Ani Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Pruritus Ani Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Pruritus Ani Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Pruritus Ani Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Pruritus Ani Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Pruritus Ani Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Pruritus Ani Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Pruritus Ani Medicine Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Pruritus Ani Medicine Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Pruritus Ani Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Pruritus Ani Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Pruritus Ani Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Pruritus Ani Medicine Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Pruritus Ani Medicine Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Pruritus Ani Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Pruritus Ani Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Pruritus Ani Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Pruritus Ani Medicine by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Pruritus Ani Medicine by Type (2020-2031)
 Figure 53. Global Pruritus Ani Medicine Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Pruritus Ani Medicine by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Pruritus Ani Medicine by Application (2020-2031)
 Figure 56. Global Pruritus Ani Medicine Price (US$/Unit) by Application (2020-2031)
 Figure 57. Pruritus Ani Medicine Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Pruritus Type Skin Diseases Medicine Market Research Report 2024
Medications for Actinic Prurigo Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cholestasis Pruritus Treatment Market Research Report 2024
Global Topical Medication for Vaginitis Market Research Report 2024
Actinic Prurigo Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pruritus Drugs Market Insights Forecast to 2030
Global Irritable Bowel Syndrome Medication Market Research Report 2025
Global Nonnarcotic Analgesics Market Research Report 2025
Global Oral Acne Medicine Market Research Report 2024
Global Irritable Bowel Syndrome Drug Market Research Report 2024
Global Trichomoniasis Drug Market Research Report 2025
Para Anisidine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anemia Drugs Market Research Report 2024
Global Dermatological Medicine Market Research Report 2024
Peripheral Neuritis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Medicine for Vaginitis Market Research Report 2024
Global Acne Vulgaris Treatment Market Research Report 2025
Global Dandruff Treatment Market Research Report 2025
Global Onychomycosis Therapy Market Research Report 2024
Global Mosquito Bite Antipruritic Agent Market Research Report 2024

RELATED REPORTS

Global Cephalosporin APIs and Cephalosporin Intermediates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19G16926
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ELISA Immunoassay Plates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7Z17064
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ready-to-Use ELISA Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20P20045
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Moxidectin Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3Z19977
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions